Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-058811
Filing Date
2023-12-15
Accepted
2023-12-15 17:04:11
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4089
  Complete submission text file 0001209191-23-058811.txt   5771
Mailing Address C/O WARNER CHILCOTT HOLDINGS CO., LTD. 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866
Business Address
Bruno Anthony D (Reporting) CIK: 0001374180 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 231491225

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations